A Review of the First Transdermal Treatment for Alzheimer’s Disease – The Rivastigmine Patch
A Review of the Neurobiology and Genetics of the Hypothalamic–Pituitary–Adrenal Axis in Suicide
Addressing the Psychiatric Sequelae of Catastrophic Trauma
Adult Attention-deficit–Hyperactivity Disorder – Clinical Features and Therapeutic Options
Adult Attention-deficit–Hyperactivity Disorder – Safety Issues in Pharmacotherapy
Age-related White Matter Changes and Disability in the Elderly
An Integrated Model of Perinatal Care
Antidepressant Medication Prevents Suicide – A Review of Ecological Studies
Antidepressant Use in Minors
Antipsychotics for Schizophrenia – Changing Minds, Minding Change
Anxiety and Insomnia – Bidirectional Associations
Are Bipolar Disorder Patients with Co-morbid Substance Use Disorder More Compromised in Social Functioning?
Best Practices and the Continuing Relevance of DSM IV TR in Contemporary Clinical Practice
Bipolar Type I Disorder and Co-occurring Substance Use Disorders
Brain Structure Findings in Schizophrenia – Implications for Aetiology
Cavum Septum Pellucidum and Adhesio Interthalamica Abnormalities in Schizophrenia
Children and Adolescents in German Youth Welfare Institutions
Chromosomal Copy Number Variation in Psychiatric Disorders
Chronic Insomnia
Clinical Benefits Associated with a Transdermal Patch for Dementia
Clinical Usefulness of Olanzapine in Bipolar Disorder—A Developer’s Insight
Cognitive Behavioral Therapy for Insomnia
Cognitive Psychotherapy and the Placebo Effect
Comorbidity Between Depressive and Addictive Disorders in Adolescents— The Role of Stress and Limbic–Hypothalamic–Pituitary–Adrenal Activity
Computerised Assessment of Visuo-spatial Cognition in Schizophrenia – An Exploratory Meta-analysis of CANTAB Findings
Contribution of Structural Brain Imaging to Our Understanding of the Cortical Development Process
Cross-national Differences in Inpatient Depression Treatment
Current Developments in Psychopharmacology for the Treatment of Depression and Schizophrenia
Current Perspectives on Augmentation of Clozapine Partial Responders with Other Antipsychotics
DAOA – An Update on Its Biology and Its Impact on Schizophrenia
Data Collection and Conduction of Pharmacoeconomic Studies in Greece
Delay of Attention-deficit–Hyperactivity Disorder Diagnosis in France – Reasons and Resolutions
Delusional Disorder
Depression as an Evolutionary Adaptation – Implications for the Development of New Drug Treatments
Development of Theory-of-Mind and the Theory-of-Mind Storybooks – Research in Typically Developing Children and Children with Autism Spectrum Disorders
Diagnosis and Management of Common Sleep Disorders – An Overview for the Psychiatrist
Dopamine Dysfunction and Delusions, Hallucinations and Anhedonia
Dronabinol Treatment for Cannabis Dependence
Dronabinol Treatment for Cannabis Dependence
Dysfunction of the Cholinergic Muscarinic Receptors and Bipolar Disorder
Early Intervention Charts as a Resource for Autism Surveillance and Research in the US
Effective Pharmacotherapy for Obsessive–Compulsive Disorder in Adults
Effectiveness of Donepezil Therapy in Advanced Alzheimer’s Disease
Efficacy and Safety of Circadin® in the Treatment of Primary Insomnia
Efficacy of Alternative Medications to Stimulants for the Treatment of Youths with Attention-deficit–Hyperactivity Disorder
Ethics Issues in Psychiatry – The World Psychiatric Association Survey
Evidence for Anatomical Alterations in the Corpus Callosum in Autism Spectrum Disorders
Evidence for the Role of Hypothalamic–Pituitary–Adrenal Axis Dysfunction in the Pathogenesis of Mood Disorders
Evidence-based Psychotherapies for Eating Disorders
Executive Functioning in Attention-deficit–Hyperactivity Disorder – Crucial or Trivial?
Exploring the Prodrome to First Psychosis
Functional Studies of Candidate Genes Involved in Attention-deficit–Hyperactivity Disorder
Gamma-aminobutyric Acid Transporter 1 as a Promising Novel Target for the Treatment of Anxiety Disorders with Panic Symptoms
Genetic Strategies for Schizophrenia
Genetic, Neurobiological and Clinical Findings Related to SHANK3 Mutations and 22q13 Chromosomal Rearrangements in Autism Spectrum Disorders
Gene–Environment Interactions in Mental Illness
Glial Activation in Schizophrenia – Evidence from Clinical Studies
How Cultural Norms May Influence Reports of Child Behaviour Problems in Different Ethnic Groups in Norway
Immune-tryptophan Pathway Interaction – Possible Pathophysiological Role in Major Depressive Disorder
Influence of Genetic and Modifiable Factors on Metabolic Consequences of Antipsychotic Drug Treatment
Intensive Cognitive Behavioural Therapy for Eating Disorders
Lithium Treatment and the Risk of Suicide in Affective Disorders
Long-term Pharmacological Management in Bipolar Disorders
Long-term Treatment of Bipolar Disorder with Carbamazepine Extended-Release Capsules in Adults, Adolescents, and Children
Managing the After-effects of Disaster Trauma – The Essentials of Early Intervention
Maternal Perinatal Depression – Impact on Infant and Child Development
Maternally Acting Gene Alleles and Neurodevelopmental Disorders – GSTP1*G313A as a Maternally Acting Allele in Autism
Maternity Blues and Post-partum Depression – Findings from Greece
Measuring Mental Health by Questionnaires in Primary Care – Unidimensionality, Responsiveness and Compliance
Mental Capital and Wellbeing
Mental Health Promotion – A Conceptual Review and Guidance
Mental Health Service Use and Unmet Needs for Care in Individuals with Schizophrenia in the US
Modafinil as an Adjunctive Treatment for Bipolar Depression
Modafinil as an Adjunctive Treatment for Bipolar Depression
Molecular Basis of X-linked Mental Retardation Using Molecular Biology and Genomic Approaches
Neurobiological Differentiation Between Borderline Patients With and Without Post-traumatic Stress Disorder
Niemann-Pick Disease Type C in Adulthood – A Psychiatric and Neurological Disorder
Niemann-Pick Disease Type C – Example of an Inborn Error of Metabolism Producing Psychiatric Manifestations
Niemann–Pick Type C Disease – Pathophysiology and Future Perspectives for Treatment
Non-pharmacological Approaches to the Treatment of Maladaptive Aggression in Children and Adolescents
Novel Pharmacotherapies for Alcohol Dependence
Obsessive–Compulsive Disorder—Chronic, Impairing, Under-recognized, and Undertreated
Optimising Attention-deficit–Hyperactivity Disorder Therapy – Efficacy and Tolerability of Equasym XL Modified-release Capsules
Patterns of Familial Response to Childhood Behavioural and Emotional Problems – An Ethnographic Study among Parents and Children in the US
Patterns of Mental Health Service Use and Unmet Needs for Care in Individuals with Schizophrenia in the US
Perceptions of Research Participation Among People with Schizophrenia
Pharmacological and Psychological Interventions for Antisocial Personality Disorder – Results of Two Cochrane Reviews
Pharmacotherapy for Attention-deficit–Hyperactivity Disorder
Pharmacotherapy for Attention-deficit–Hyperactivity Disorder
Pharmacotherapy of Obsessive–Compulsive Disorders
Pichot – A Tribute to the European Pharmacopsychologist on His 90th Birthday
Platelet Monoamine Oxidase Activity and Aggressive Obsessions
Positive Antidepressant Pharmacotherapy in Reducing Suicide Morbidity and Mortality in Unipolar Depression
Potential Biomarkers in Studying Autism and Other Neurodevelopmental Disorders
Pre-clinical Profiling of Antipsychotics – New Data and Implications for Clinical Outcome
Predictors of Offending and Critical Incidents among Prisoners
Provision of Psychiatric Services and Mental Healthcare Reform in Eastern Europe and the Balkans
Psychiatric Issues in Cancer
Psychiatric Issues in Cancer
Psychiatric Manifestations of Niemann-Pick Disease
Psychiatric Professionalism, Multidisciplinary Teams and Clinical Practice
Psychomotor Functioning in Chronic Fatigue Syndrome and Major Depressive Disorder
Psychomotor Psychoses – The Enigmatic Catatonic Phenotype
Quetiapine XR – A New Retard Formulation in the Treatment of Schizophrenia
Randomised Controlled Trials in Intellectual Disabilities and Challenging Behaviours – Current Practice and Future Challenges
Refinements to the Maintenance of Certification Program
Risperidone versus Haloperidol in Children and Adolescents with Autism
Rivastigmine in the Treatment of Alzheimer’s Disease and Parkinson’s Disease Dementia
Role of Atypical Antipsychotics in the Management of Mania and Depression in Bipolar Disorder Patients
Role of Brain-derived Neurotrophic Factor in Depression-related Behaviour – Could it Explain the Higher Incidence in Females?
Role of the X Chromosome in Social Behavioural Dysfunction and Autism-like Behaviour
Sensitive Periods in Brain Development – Implications for Education Policy
Sequential Use of Pharmacotherapy and Psychotherapy in Mood Disorders
Sertindole in Clinical Practice
Sex Differences Among Adult Non-treated Patients with Attention-deficit–Hyperactivity Disorder
Sustainable Treatments for Depression in Developing Countries
The Bi-directional Association Between Insomnia and Anxiety
The Complexity of Development Trends and Decision-making in Pharmacopsychiatry
The Current Status of Vascular Depression
The Genetics of Schizophrenia—Is This a Time for Revising the ‘Method’?
The Influence of Anxiety as a Risk Factor for Major Depression
The Leonhardean Classification of Endogenous Psychoses – Predictive Validity at Two Subsequent Follow-ups in a Long-term Prospective Study (Budapest 2000)
The Manic Wing of the Bipolar Spectrum
The Neurobiology of Anorexia Nervosa
The Pharmacotherapy of Social Anxiety Disorder
The Rationale for Selective α2A Adrenergic Agonists in the Treatment of Attention-deficit–Hyperactivity Disorder
The Redox/Methylation Hypothesis of Autism
The Relevance of Anxious Depression as a Distinct Entity for Psychopharmacology and Drug Development
The Scottish Schizophrenia Outcomes Study – A New Paradigm for Utilising Self-report Assessments from Patients with Schizophrenia
The Serotonin Transporter Gene and Response to Antidepressants in Young People – A Review
The Shift of Responsibility in Care Processes during the Last Decades
The Significance of Cognitive Functioning, Physical Health and Early Non-response in Schizophrenia
The Use of Rating Scales in Affective Disorders
The Wisconsin Card Sorting Test, the Wechsler Memory Scale Revised, and the Verbal Associative Fluency Test in Assessing Executive Function Abnormality in Pathological Gamblers
Transdiagnostic Cognitive–Behavioural Therapy for Patients with Eating Disorders
Trauma and Stigma as Defeating Experiences Over the Life Course Interacting with Genetic Liability in Schizophrenia
Treating Insomnia and Depression – The Evidence for Eszopiclone
Treating Major Depressive Disorder in Adults in Primary Care— What to Expect from Escitalopram
Treatment and Monitoring Guidelines for the Patient with Bipolar Disorder
Treatment Strategies and Tactics for Treatment-resistant Depression
Tryptophan Metabolism as a New Target for the Treatment of Schizophrenia
Understanding Brain Anatomy in Autism – Findings from Structural Neuroimaging
Use of Item Response Theory Methodology to Evaluate Differences Between Bipolar and Unipolar Depression
Use of Resting-state Functional Magnetic Resonance Imaging to Measure Functional Connectivity in Adolescents with Depression
Validity of Three Pervasive Developmental Disorder (PDD) Subtypes— Autistic Disorder, Asperger’s Disorder, and PDD Not Otherwise Specified
Weight and Psychological Problems in 10–17-year-old German Pupils
Which Risk Factors at Baseline and During Treatment Predict Short-term Persistence of Major Depression in Adolescents?
Why Are Children and Adolescents with 22q11.2 Deletion Syndrome at High Risk of Developing Schizophrenia?
close

This content is copyright protected

However, if you would like to share the information on this webpage, you may use the headline and link below:

Read more: